CDC Alert Documents 1,645 Confirmed Cases in Multistate Cyclospora Outbreak
A July 14 health notice tied the seasonal surge to 34 states and 141 hospitalizations, with a food source still under FDA investigation.
Health News
Drug approvals, product recalls, safety advisories and revised clinical guidance, written so a reader knows immediately whether it applies to them.
FDA Approves Simtriyo, a First-in-Class Nonstimulant Pill for ADHD
Otsuka's centanafadine, the first approved norepinephrine, dopamine, and serotonin reuptake inhibitor, is cleared for patients 6 and older.
FDA Approves Zidesamtinib for ROS1-Positive Lung Cancer After Progression
The agency cleared Jideytro on July 22, 2026 for patients whose ROS1-positive non-small cell lung cancer advanced on a prior ROS1 inhibitor.
FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
Merck's once-daily Lipfendra (enlicitide) cut LDL cholesterol by nearly 60 percent in trials and offers an alternative to injections.
FDA Approves Lumvoa for Thyroid Eye Disease, Including Chronic Cases
The second IGF-1R antibody cleared for the condition extends targeted treatment to patients in both active and chronic stages, its developer says.
FDA Approves First Oral Antiviral to Prevent COVID-19 After Exposure
Xocova (ensitrelvir) cut the risk of symptomatic infection by about 67 percent in the SCORPIO-PEP trial and is cleared for people 12 and older.